Megan Hanson
Gastroenterology · Charleston, WVNPI 1922503515
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 639 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AbbVie at 27.7% of the total. Reporting peaked in 2022 at $2,980 and has fallen 71.8% since, to $839 in 2025.
Across 639 payments — averaging $16.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Johnson & Johnson$910
- Ardelyx, Inc.$503
- Sanofi$412
- plus $3K from 23 others
What the payments were for
- Food & beverage$10,39599%
- Education$1151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 215 | $2,912 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 116 | $1,725 |
| Takeda Pharmaceuticals U.S.A., Inc. | 91 | $1,542 |
| Johnson & Johnson | 34 | $910 |
| Ardelyx, Inc. | 31 | $503 |
| Sanofi | 17 | $412 |
| Regeneron Healthcare Solutions, Inc. | 17 | $361 |
| Redhill Biopharma Inc. | 21 | $300 |
| Pfizer | 15 | $292 |
| Intercept Pharmaceuticals, Inc. | 16 | $272 |
| Bristol Myers Squibb | 12 | $198 |
| QOL Medical, LLC | 9 | $176 |
| Merck | 9 | $158 |
| Nestle Healthcare Nutrition Inc. | 1 | $110 |
| Madrigal Pharmaceuticals | 5 | $93 |
| Gilead | 5 | $80 |
| Celltrion USA Inc. | 3 | $77 |
| Boehringer Ingelheim | 3 | $58 |
| Axonics, Inc. | 3 | $50 |
| Novo Nordisk | 3 | $44 |
| Daiichi Sankyo Inc. | 2 | $43 |
| Evoke Pharma, Inc. | 2 | $38 |
| Aimmune Therapeutics, Inc. | 2 | $37 |
| Amgen | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 2 | $25 |
| Braintree Laboratories, Inc. | 1 | $17 |
| Mallinckrodt Hospital Products Inc. | 1 | $16 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZENPEP$110
How this compares
$10,510 in reported general payments places this provider in the 80th percentile of 72 gastroenterology providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 42 | $184,961 |
| LinzessLinaclotide | 85 | $89,305 |
| XifaxanRifaximin | 31 | $86,834 |
| Mesalamine ErMesalamine | 27 | $9,846 |
| Colestipol Hcl | 56 | $7,954 |
| Famotidine | 269 | $3,260 |
| Hydrocortisone | 18 | $3,061 |
| Pantoprazole Sodium | 185 | $2,055 |
| Omeprazole | 127 | $1,255 |
| Lansoprazole | 16 | $1,197 |
| Ondansetron OdtOndansetron | 63 | $1,170 |
| Lactulose | 21 | $1,128 |
| Esomeprazole Magnesium | 24 | $1,096 |
| Sucralfate | 31 | $963 |
| Dicyclomine Hcl | 55 | $914 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess | $2,912 | $274,266127 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $1,725 | $86,83431 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 72 gastroenterology providers in West Virginia.
Other gastroenterology in Charleston
- Muhammad BashirCharleston$7K
- Jeremy StapletonCharleston$7K
- Jeremy CumberledgeCharleston$7K
- Marc SubikCharleston$2K
- Mohamad SankariCharleston$1K
- Roberta HunterCharleston$769
- Vishnu Vardhan Reddy NaravadiCharleston$285
- Jennifer VeverkaMorgantown$283K
- Shailendra SinghMorgantown$187K
- Mohamad HaffarSouth Charleston$118K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.